IL84790A - Pharmaceutical compositions containing 3)-deoxythymidin-2)-ene (3)-deoxy-2), 3)-didehydrothymidine) for treating patients infected with retroviruses - Google Patents

Pharmaceutical compositions containing 3)-deoxythymidin-2)-ene (3)-deoxy-2), 3)-didehydrothymidine) for treating patients infected with retroviruses

Info

Publication number
IL84790A
IL84790A IL84790A IL8479087A IL84790A IL 84790 A IL84790 A IL 84790A IL 84790 A IL84790 A IL 84790A IL 8479087 A IL8479087 A IL 8479087A IL 84790 A IL84790 A IL 84790A
Authority
IL
Israel
Prior art keywords
deoxythymidin
didehydrothymidine
deoxy
ene
retroviruses
Prior art date
Application number
IL84790A
Other languages
English (en)
Other versions
IL84790A0 (en
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25478432&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL84790(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Yale filed Critical Univ Yale
Publication of IL84790A0 publication Critical patent/IL84790A0/xx
Publication of IL84790A publication Critical patent/IL84790A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IL84790A 1986-12-17 1987-12-11 Pharmaceutical compositions containing 3)-deoxythymidin-2)-ene (3)-deoxy-2), 3)-didehydrothymidine) for treating patients infected with retroviruses IL84790A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/942,666 US4978655A (en) 1986-12-17 1986-12-17 Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses

Publications (2)

Publication Number Publication Date
IL84790A0 IL84790A0 (en) 1988-05-31
IL84790A true IL84790A (en) 1993-03-15

Family

ID=25478432

Family Applications (1)

Application Number Title Priority Date Filing Date
IL84790A IL84790A (en) 1986-12-17 1987-12-11 Pharmaceutical compositions containing 3)-deoxythymidin-2)-ene (3)-deoxy-2), 3)-didehydrothymidine) for treating patients infected with retroviruses

Country Status (22)

Country Link
US (1) US4978655A (de)
EP (1) EP0273277B1 (de)
JP (1) JPH07116041B2 (de)
KR (1) KR960000433B1 (de)
AT (1) ATE77554T1 (de)
AU (1) AU593405B2 (de)
CA (1) CA1293447C (de)
DE (1) DE3780016T2 (de)
DK (1) DK174627B1 (de)
EG (1) EG19157A (de)
ES (1) ES2038650T3 (de)
FI (1) FI875544A (de)
GR (1) GR3005691T3 (de)
HK (1) HK55896A (de)
IE (1) IE60866B1 (de)
IL (1) IL84790A (de)
LU (1) LU88822I2 (de)
NL (1) NL960024I2 (de)
NZ (1) NZ222935A (de)
PH (1) PH26380A (de)
PT (1) PT86346B (de)
ZA (1) ZA877171B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175292A (en) * 1988-01-20 1992-12-29 Regents Of The University Of Minnesota Intermediates for the preparation of dideoxycarbocyclic nucleosides
US5631370A (en) * 1988-01-20 1997-05-20 Regents Of The University Of Minnesota Optically-active isomers of dideoxycarbocyclic nucleosides
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
US6207650B1 (en) 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
US5608048A (en) * 1995-06-05 1997-03-04 Bristol-Myers Squibb Company d4 T polymorphic Form 1 process
US5840711A (en) * 1995-06-21 1998-11-24 University Of Kentucky Research Foundation Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
CA2189097A1 (en) 1995-11-15 1997-05-16 Pin-Fang Lin Composition and method of treating retroviral infection
US5719132A (en) * 1996-06-27 1998-02-17 Bristol-Myers Squibb Company Compositions and methods of treating HIV with d4T, 5-fluorouracil/tegafur, and uracil
WO2000016625A1 (en) * 1998-09-23 2000-03-30 University Of Kentucky Research Foundation Antiviral drug compositions containing lithium inorganic salts
NZ522250A (en) 2000-03-30 2004-09-24 Bristol Myers Squibb Co Sustained release beadlets containing stavudine stabilised by magnesium stearate
EP2316468A1 (de) 2002-02-22 2011-05-04 Shire LLC Abgabesystem und Verfahren zum Schutz und zur Verabreichung von Dextroamphetamin
BRPI0407374A (pt) 2003-02-19 2006-01-10 Univ Yale Análogos de nucleosìdeo antiviral e métodos para tratar infecções virais, especialmente infecções de hiv
US20040200730A1 (en) * 2003-04-14 2004-10-14 Kyo Jibiki Hydrometallurgical copper recovery process
ATE505196T1 (de) 2004-07-27 2011-04-15 Gilead Sciences Inc Nukleosid phosphonat konjugate als anti hiv mittel
AP2008004389A0 (en) * 2005-08-31 2008-04-30 Cipla Ltd Pharmaceutical combinations containing lamivudine,stavudine,stavudine and navirapine
CN102272134B (zh) 2008-12-09 2013-10-16 吉里德科学公司 Toll样受体调节剂
US20110223131A1 (en) 2010-02-24 2011-09-15 Gilead Sciences, Inc. Antiviral compounds
WO2016001907A1 (en) 2014-07-02 2016-01-07 Prendergast Patrick T Mogroside iv and mogroside v as agonist/stimulator/un-blocking agent for toll-like receptor 4 and adjuvant for use in human/animal vaccine and to stimulate immunity against disease agents.
MX2017000026A (es) 2014-07-11 2017-05-01 Gilead Sciences Inc Moduladores de receptores tipo toll para el tratamiento de virus de inmunodeficiencia humana (vih).
US20180263985A1 (en) 2015-09-15 2018-09-20 Gilead Sciences, Inc. Modulators of toll-like receptors for the treatment of hiv

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322747A (en) * 1965-04-01 1967-05-30 Merck & Co Inc Thionocarbonate nucleosides
US3817982A (en) * 1971-12-29 1974-06-18 Syntex Inc 2{40 ,3{40 -unsaturated nucleosides and method of making
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
JPS5943550B2 (ja) * 1975-08-29 1984-10-23 田辺製薬株式会社 不飽和ヌクレオシドの製法
DE3515870A1 (de) * 1985-05-03 1986-11-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 5-fluortoluol-2,4-disulfochlorid
US4710492A (en) * 1986-06-23 1987-12-01 Yale University 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses
NL8700089A (nl) * 1987-01-15 1988-08-01 Stichting Rega V Z W Therapeutische toepassing van dideoxythymidine en dideoxythymidineen.
DE3806633A1 (de) * 1987-09-01 1989-03-09 Bayer Ag Antivirales mittel
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
JPH0227782A (ja) * 1988-07-15 1990-01-30 Hikari Gijutsu Kenkyu Kaihatsu Kk 半導体発光素子
JPH0438727A (ja) * 1990-06-04 1992-02-07 Sharp Corp 光学式ピックアップ装置の対物レンズ塵埃付着防止機構

Also Published As

Publication number Publication date
NL960024I2 (nl) 1997-06-02
AU593405B2 (en) 1990-02-08
CA1293447C (en) 1991-12-24
ES2038650T3 (es) 1993-08-01
FI875544A (fi) 1988-06-18
LU88822I2 (fr) 1997-01-06
DK557087D0 (da) 1987-10-23
DE3780016T2 (de) 1992-12-24
ZA877171B (en) 1988-03-24
DK557087A (da) 1988-06-18
PT86346A (en) 1988-01-01
PT86346B (pt) 1990-11-07
NL960024I1 (nl) 1996-12-02
GR3005691T3 (de) 1993-06-07
PH26380A (en) 1992-06-01
DE3780016D1 (de) 1992-07-30
KR960000433B1 (ko) 1996-01-06
DK174627B1 (da) 2003-07-28
EP0273277A3 (en) 1989-09-13
IE873245L (en) 1988-06-17
ATE77554T1 (de) 1992-07-15
KR880007079A (ko) 1988-08-26
FI875544A0 (fi) 1987-12-16
JPS63215632A (ja) 1988-09-08
IL84790A0 (en) 1988-05-31
AU8090087A (en) 1988-06-23
EP0273277B1 (de) 1992-06-24
JPH07116041B2 (ja) 1995-12-13
EP0273277A2 (de) 1988-07-06
NZ222935A (en) 1990-09-26
US4978655A (en) 1990-12-18
IE60866B1 (en) 1994-08-24
EG19157A (en) 1994-09-29
HK55896A (en) 1996-04-03

Similar Documents

Publication Publication Date Title
IL84790A (en) Pharmaceutical compositions containing 3)-deoxythymidin-2)-ene (3)-deoxy-2), 3)-didehydrothymidine) for treating patients infected with retroviruses
MY119031A (en) Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses
NZ226845A (en) 2', 3'-dideoxy-2'-fluoronucleosides; pharmaceutical compositions and processes for their preparation
EP0296573A3 (en) Novel nucleosides, their preparation and pharmaceutical novel nucleosides, their preparation and pharmaceutical compositions compositions
EG18441A (en) Process for preparing 2,3-dideoxycytidin-2-ene(2,3-dideoxy-2,3-dideoxy drocytidine)in treating patients infected with retroviruses
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
IL86077A0 (en) Receptor of the small rhinovirus receptor group,its preparation and pharmaceutical compositions containing it
IL90499A0 (en) Therapeutic uses of 2',5'-oligoadenylates
EP0311108A3 (de) Anti-HIV-aktive 3'-Azido-2,6-diaminopurine-2',3'-dideoxyriboside

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired